Data / Form D filings / Zyus Life Sciences Inc.
Zyus Life Sciences Inc.: Form D filings
Zyus Life Sciences Inc., a health care company in Saskatoon, Saskatchewan, Canada, filed 8 Form D notices with the SEC between 2018 and 2023. The latest, on June 20, 2023, reports $1.1 million sold of a $1.1 million offering to 6 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 407 DOWNEY RD, SUITE 204, Saskatoon, Saskatchewan, Canada, S7N 4
- Phone
- (306) 651-7711
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Saskatchewan, Canada
- Year incorporated
- 2018
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1757610
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 20, 2023 | New notice | $1,147,152 | $1,147,152 | 6 | Jun 5, 2023 | sec.gov | |
| Mar 2, 2023 | New notice | $1,484,600 | $18,557 | $1,466,043 | 1 | Feb 16, 2023 | sec.gov |
| Nov 3, 2021 | New notice | $5,000,000 | $2,068,000 | $2,932,000 | 2 | Oct 20, 2021 | sec.gov |
| Jan 6, 2021 | Amendment | $19,204,000 | $15,068,994 | $4,135,006 | 6 | Nov 26, 2020 | sec.gov |
| Dec 11, 2020 | New notice | $312,034 | $312,034 | 4 | Nov 26, 2020 | sec.gov | |
| Aug 13, 2019 | New notice | $18,101,444 | $7,783,620 | $10,317,824 | 47 | Jul 31, 2019 | sec.gov |
| May 20, 2019 | New notice | $18,562,500 | $2,366,788 | $16,195,712 | 8 | May 3, 2019 | sec.gov |
| Oct 31, 2018 | New notice | $19,046,176 | $11,930,525 | $7,115,651 | 49 | Oct 16, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| John Knowles | Director | |
| Dr. Lionel Marks de Chabris | Executive Officer | |
| Garnette Weber | Director | |
| Richard Hoyt | Director | |
| John Hyshka | Executive Officer | |
| Keith Carpenter | Executive Officer | |
| BRENT ZETTL | Executive Officer |
Every Form D from the week of Jun 19, 2023 · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what Zyus Life Sciences Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.